Analogue peptides for the immunotherapy of human acute myeloid leukemia.
about
Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes.Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies.Peptide vaccines in cancer-old concept revisited.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.
P2860
Analogue peptides for the immunotherapy of human acute myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Analogue peptides for the immunotherapy of human acute myeloid leukemia.
@en
type
label
Analogue peptides for the immunotherapy of human acute myeloid leukemia.
@en
prefLabel
Analogue peptides for the immunotherapy of human acute myeloid leukemia.
@en
P2093
P2860
P1476
Analogue peptides for the immunotherapy of human acute myeloid leukemia
@en
P2093
Aleksandrs Malinovskis
Nicola R Hardwick
Susanne Hofmann
P2860
P2888
P304
P356
10.1007/S00262-015-1762-9
P577
2015-10-05T00:00:00Z
P5875
P6179
1053032300